JP2007507480A5 - - Google Patents

Download PDF

Info

Publication number
JP2007507480A5
JP2007507480A5 JP2006530592A JP2006530592A JP2007507480A5 JP 2007507480 A5 JP2007507480 A5 JP 2007507480A5 JP 2006530592 A JP2006530592 A JP 2006530592A JP 2006530592 A JP2006530592 A JP 2006530592A JP 2007507480 A5 JP2007507480 A5 JP 2007507480A5
Authority
JP
Japan
Prior art keywords
fibrinogen
product
platelet
platelets
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006530592A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507480A (ja
JP4938454B2 (ja
Filing date
Publication date
Priority claimed from GBGB0323378.0A external-priority patent/GB0323378D0/en
Application filed filed Critical
Publication of JP2007507480A publication Critical patent/JP2007507480A/ja
Publication of JP2007507480A5 publication Critical patent/JP2007507480A5/ja
Application granted granted Critical
Publication of JP4938454B2 publication Critical patent/JP4938454B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006530592A 2003-10-07 2004-10-07 止血を促進するためのフィブリノゲン標的微粒子 Expired - Fee Related JP4938454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0323378.0A GB0323378D0 (en) 2003-10-07 2003-10-07 Therapeutic agent
GB0323378.0 2003-10-07
PCT/GB2004/004235 WO2005035002A1 (en) 2003-10-07 2004-10-07 Fibrinogen targetting microparticles for promoting haemostasie

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011143587A Division JP2011184465A (ja) 2003-10-07 2011-06-28 止血を促進するためのフィブリノゲン標的微粒子

Publications (3)

Publication Number Publication Date
JP2007507480A JP2007507480A (ja) 2007-03-29
JP2007507480A5 true JP2007507480A5 (https=) 2007-11-22
JP4938454B2 JP4938454B2 (ja) 2012-05-23

Family

ID=29415609

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006530592A Expired - Fee Related JP4938454B2 (ja) 2003-10-07 2004-10-07 止血を促進するためのフィブリノゲン標的微粒子
JP2011143587A Withdrawn JP2011184465A (ja) 2003-10-07 2011-06-28 止血を促進するためのフィブリノゲン標的微粒子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011143587A Withdrawn JP2011184465A (ja) 2003-10-07 2011-06-28 止血を促進するためのフィブリノゲン標的微粒子

Country Status (9)

Country Link
US (1) US20080064628A1 (https=)
EP (1) EP1677829B1 (https=)
JP (2) JP4938454B2 (https=)
CN (1) CN1863560A (https=)
AU (1) AU2004280115B2 (https=)
CA (1) CA2541005C (https=)
GB (1) GB0323378D0 (https=)
IL (1) IL174580A0 (https=)
WO (1) WO2005035002A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516091D0 (en) * 2005-08-04 2005-09-14 Haemostatix Ltd Therapeutic agent
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US9114127B2 (en) * 2007-05-15 2015-08-25 Richard C. K. Yen Biologic devices for hemostasis
KR20100057642A (ko) * 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 치료제로서의 ｃｎｐ-２２ 단독 또는 피살라에민과 배합된 이의 용도
WO2009046845A2 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of a lactoferrin partial peptide peptide as a therapeutic agent
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
GB201204868D0 (en) 2012-03-20 2012-05-02 San Raffaele Centro Fond Peptides
AU2013334180A1 (en) * 2012-10-25 2015-05-14 The Children's Hospital Of Philadelphia Affinity peptide-modified particles and targeted drug delivery methods
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
WO2017103914A1 (en) 2015-12-17 2017-06-22 Regentis Biomaterials Ltd. Ready for use organic solvent free compositions comprising protein-polymer conjugates and uses thereof
EP3887404A4 (en) 2018-11-30 2022-11-02 Cellphire, Inc. SLIDES LOADED WITH ANTI-CANCER AGENTS
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
AU2020267368B2 (en) 2019-05-03 2023-05-04 Cellphire, Inc. Materials and methods for producing blood products
CN110448719B (zh) * 2019-06-28 2020-05-22 浙江大学 一种促进凝血的丝素-多肽电纺膜及其制备方法
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN AGENT FOR REMOVING THE THROMBOCYTE AGGREGATION-INHIBITING EFFECT
CA3170201A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Methods of treating congenital hemophilia with anti-fibrinolytic loaded platelets
TW202245814A (zh) 2021-02-17 2022-12-01 美商賽菲爾公司 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物
JP2024539653A (ja) * 2021-10-15 2024-10-29 ノース カロライナ ステート ユニバーシティ 生体液を精製するための組成物及び方法
GB2642384A (en) * 2023-01-31 2026-01-07 Univ North Carolina State Compositions and methods for purifying biological fluids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US6391343B1 (en) * 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
DE4310632A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Lineare Adhäsionsinhibitoren
PT796090E (pt) * 1994-12-16 2003-07-31 Elan Drug Delivery Ltd Microparticulas reticuladas e sua utilizacao como veiculos terapeuticos
ES2232862T3 (es) 1996-10-21 2005-06-01 Quadrant Drug Delivery Limited Sustitutos de plaquetas y procedimientos de conjugacion apropiados para su preparacion.
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
WO1999042146A1 (en) 1998-02-20 1999-08-26 Quadrant Healthcare (Uk) Limited Products comprising fibrinogen for use in therapy
WO2004045542A2 (en) 2002-11-15 2004-06-03 Arizona Board Of Regents Arizona State University Therapeutic bioconjugates

Similar Documents

Publication Publication Date Title
JP2011184465A (ja) 止血を促進するためのフィブリノゲン標的微粒子
JP2007507480A5 (https=)
Satta et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide.
JP5204490B2 (ja) 出血の制御及び出血性疾患の治療のための止血剤としての細胞由来微粒子
US20130029913A1 (en) Artificial platelets
HU214884B (hu) Vérlemezke membrán mikrorészecskék, ezeket tartalmazó gyógyászati és diagnosztikai készítmények és eljárás a mikrórészecskék és a készítmények előállítására
Ghiran et al. Expression and function of C1q receptors and C1q binding proteins at the cell surface
WO2008121721A2 (en) Targeted delivery and expression of procoagulant hemostatic activity
JP6636443B2 (ja) 出血性症候群の場合における失血を制御する及び／又は血小板の代用にすることが可能であるコラーゲンに基づいた注射用製剤
US20250073271A1 (en) Methods of administering platelet derivative compositions to reduce bleeding in subjects refractory to platelet transfusion
Sloand et al. DDAVP corrects the platelet dysfunction produced by cardiopulmonary by-pass, hemodialysis, and prolonged storage: Re-expression of glycoprotein Ib on the platelet membrane
Bauer et al. Blood, plasma proteins, coagulation, fibrinolysis, and thrombocyte function
JP2020508963A (ja) Ｒｍｐ組成物および使用方法